Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11044 | 946 | 26.1 | 56% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CA 15 3 | Author keyword | 56 | 48% | 9% | 86 |
2 | CA 153 | Author keyword | 32 | 62% | 3% | 33 |
3 | TISSUE POLYPEPTIDE SPECIFIC ANTIGEN | Author keyword | 21 | 51% | 3% | 30 |
4 | CA15 3 | Author keyword | 15 | 45% | 3% | 25 |
5 | CA153 | Author keyword | 12 | 56% | 2% | 15 |
6 | MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN | Author keyword | 12 | 86% | 1% | 6 |
7 | CA 549 | Author keyword | 11 | 78% | 1% | 7 |
8 | TISSUE POLYPEPTIDE ANTIGEN | Author keyword | 8 | 30% | 2% | 22 |
9 | TISSUE POLYPEPTIDE SPECIFIC ANTIGEN TPS | Author keyword | 7 | 67% | 1% | 6 |
10 | MUCIN MARKERS | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CA 15 3 | 56 | 48% | 9% | 86 | Search CA+15+3 | Search CA+15+3 |
2 | CA 153 | 32 | 62% | 3% | 33 | Search CA+153 | Search CA+153 |
3 | TISSUE POLYPEPTIDE SPECIFIC ANTIGEN | 21 | 51% | 3% | 30 | Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN | Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN |
4 | CA15 3 | 15 | 45% | 3% | 25 | Search CA15+3 | Search CA15+3 |
5 | CA153 | 12 | 56% | 2% | 15 | Search CA153 | Search CA153 |
6 | MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN | 12 | 86% | 1% | 6 | Search MUCIN+LIKE+CARCINOMA+ASSOCIATED+ANTIGEN | Search MUCIN+LIKE+CARCINOMA+ASSOCIATED+ANTIGEN |
7 | CA 549 | 11 | 78% | 1% | 7 | Search CA+549 | Search CA+549 |
8 | TISSUE POLYPEPTIDE ANTIGEN | 8 | 30% | 2% | 22 | Search TISSUE+POLYPEPTIDE+ANTIGEN | Search TISSUE+POLYPEPTIDE+ANTIGEN |
9 | TISSUE POLYPEPTIDE SPECIFIC ANTIGEN TPS | 7 | 67% | 1% | 6 | Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN+TPS | Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN+TPS |
10 | MUCIN MARKERS | 6 | 80% | 0% | 4 | Search MUCIN+MARKERS | Search MUCIN+MARKERS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CA 15 3 | 134 | 60% | 16% | 147 |
2 | CA 153 | 73 | 85% | 4% | 39 |
3 | CA15 3 | 64 | 69% | 6% | 55 |
4 | MCA | 21 | 48% | 3% | 32 |
5 | TPS | 18 | 43% | 3% | 32 |
6 | CA 549 | 15 | 71% | 1% | 12 |
7 | POSTOPERATIVE FOLLOW UP | 10 | 42% | 2% | 19 |
8 | POLYPEPTIDE SPECIFIC ANTIGEN | 7 | 30% | 2% | 21 |
9 | KERATIN 18 | 7 | 30% | 2% | 20 |
10 | CA153 | 7 | 67% | 1% | 6 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF TUMOR MARKER ONCOLOGY | 2 | 11% | 2% | 19 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tumour marker measurements in the diagnosis and monitoring of breast cancer | 2000 | 103 | 71 | 63% |
Serum tumor markers in breast cancer: Are they of clinical value? | 2006 | 158 | 50 | 64% |
CA 15-3: Uses and limitation as a biomarker for breast cancer | 2010 | 43 | 63 | 54% |
Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer | 2014 | 7 | 63 | 32% |
Tumor markers in breast cancer - European Group on Tumor Markers recommendations | 2005 | 135 | 112 | 41% |
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer | 1996 | 351 | 300 | 18% |
CA 15-3 and related mucins as circulating markers in breast cancer | 1999 | 48 | 39 | 64% |
Tumor Markers in Breast Cancer - Evaluation of their Clinical Usefulness | 2011 | 15 | 45 | 27% |
Standards, Options and Recommendations (SOR) for tumor markers in breast cancer | 2000 | 14 | 73 | 84% |
Interest of tumour markers: What places for the ACE and the CA 15-3? | 2010 | 2 | 49 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REG INDICATORI BIOCHIM TUMORE | 1 | 38% | 0.3% | 3 |
2 | UO CHIRURG 1 | 1 | 40% | 0.2% | 2 |
3 | STUDY BIOL MARKERS MALIGNANCY | 1 | 17% | 0.5% | 5 |
4 | REPROD AGING | 1 | 13% | 0.5% | 5 |
5 | ASSOC ABO | 1 | 50% | 0.1% | 1 |
6 | CHEMOTHER Y OUTPATIENT | 1 | 50% | 0.1% | 1 |
7 | CLINICO MED | 1 | 50% | 0.1% | 1 |
8 | HEMATOL CLIN SERV | 1 | 50% | 0.1% | 1 |
9 | MED STAT BIOMETR G A MACCACARO | 1 | 50% | 0.1% | 1 |
10 | ORAL BIOMECH BIOTECHNOL UNIT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000180521 | MUC1//MUC1 MUCIN//MUC 1 |
2 | 0.0000152027 | CYFRA 21 1//CYTOKERATIN 19 FRAGMENTS//PROGRP |
3 | 0.0000122922 | CA 19 9//CA19 9//SPAN 1 |
4 | 0.0000112048 | CA 242//PREOPERATIVE CEA LEVEL//POSTOPERATIVE SURVEILLANCE |
5 | 0.0000109929 | CA 125//HE4//HUMAN EPIDIDYMIS PROTEIN 4 |
6 | 0.0000084367 | M65//M30//M65 ELISA |
7 | 0.0000082975 | SURVIVORSHIP CARE PLANS//SURVIVORSHIP CARE PLAN//TREATMENT SUMMARIES |
8 | 0.0000074703 | SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3 |
9 | 0.0000059801 | B2T//BREAST DIS UNIT//POSITRON EMISSION MAMMOGRAPHY |
10 | 0.0000056799 | CEACAM1//BILIARY GLYCOPROTEIN//CD66A |